Experience

    • Canson in the formation of its $100 million co-investment fund, which will co-invest in the acquisition of a majority stake in the Financial and Risk division of Thomson Reuters.
    • Norilsk Nickel in its up to $2.5 billion syndicated term loan facility with an international syndicate comprising 17 banks and financial institutions.
    • NLMK in its $500 million Eurobond offering of 4% notes due 2024, and a related tender offer for outstanding notes due 2018 and 2019 for the aggregate principal amount of $317 million.
    • Metric Capital Partners in its €100 million subscription facility with Citibank.
    • Nornickel in its $1 billion Eurobond offering of 4.10% notes due 2023.
    • Metric Capital Partners in the formation of MCP Private Capital Fund III, an €850 million European special opportunities fund.
    • NLMK and its U.S. subsidiaries in a $250 million ABL facility.
    • Polyus Gold International in its $500 million Eurobond offering of 4.699% notes due 2022.
    • PartnerRe in its €750 million debut Eurobond offering of 1.25% notes due 2026.
    • NLMK in its $700 million Eurobond offering of 4.5% loan participation notes due 2023, and a related tender offer for its outstanding notes due 2018 and 2019 for the aggregate principal amount of $571 million.
    • Park Square in the formation of Park Square Capital Partners III, a €1.2 billion subordinated debt fund.
    • HarbourVest Partners in its co-investment with IK Investment Partners in the Salad Signature group, a Dutch and Belgian food business.
    • Prudential Financial in its $350 million partnership with LeapFrog Investments, targeting investments in life insurance companies in Africa.
    • NLMK Group in its $400 million pre-export finance facility.
    • Norilsk Nickel in its $1 billion Eurobond offering of 6.625% notes due 2022.
    • Lannett in its acquisition for $1.23 billion in cash, plus additional contingent consideration, of Kremers Urban Pharmaceuticals, the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB.
    • Park Square in the formation of Park Square Capital Credit Opportunities II, a $2.4 billion senior debt programme.
    • NLMK Europe Plate Division in its €250 million revolving collateralized credit facility.
    • AXA in the sale of its mandatory pension business in Hong Kong to the Principal Financial Group.
    • Exponent Private Equity Partners in the formation of Exponent Private Equity Partners III, a £1 billion UK buyout fund.
    • HarbourVest Partners as a selling shareholder, together with Exponent, in the purchase of Trainline by KKR.
    • Knighthead Capital Management in its formation and capitalization of Knighthead Holdings Ltd., a Cayman Islands-based annuity provider.
    • Ares Management in the formation of Ares Europe Real Estate Fund IV, a $1.3 billion Europe real estate fund.
    • Clayton, Dubilier & Rice in tax aspects of its €1.2 billion acquisition of Mauser Group, a leading provider of industrial packaging.
    • A consortium including HarbourVest Partners and Coller Capital, in their secondary purchase of interests in Absa Capital Private Equity Fund I from Barclays Africa Group, formerly known as Absa Capital, as part of a spin-out of Absa Capital Private Equity from the Absa Group.
    • AREA in its formation of its European real estate funds.
    • Eutelsat Communications in its $1.14 billion acquisition of Satélites Mexicanos.

Education

  • New York University, 2014, LL.M.
  • University of Texas at Austin, 2009, J.D.
  • Rutgers University, 2002, B.S.